General Motors (GM) Tops Q3 EPS by 31c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
UBS Raises Price Target on General Motors (GM) Following a $0.31 EPS Beat in Q3
October 22, 2015 11:57 AM EDTUBS reiterated a Buy rating on General Motors (NYSE: GM), and raised the price target to $50.00 (from $48.00), following the company's 3Q15 earnings results. GM reported a $0.31 Q3 beat vs. consensus. Adjusted EBIT of $3.1bn beat consensus of $2.7bn, reflecting strong margin growth in... More
Wall St. declines; Valeant, healthcare weigh
October 21, 2015 7:08 AM EDTBy Caroline Valetkevitch
(Reuters) - U.S. stocks fell on Wednesday as a sharp drop in Valeant Pharmaceuticals hit the healthcare space, while the energy sector dropped along with oil prices.
Valeant Pharmaceuticals' (NYSE: VRX) U.S.-listed shares plunged to an intraday low of $88.50 on record volume after a short-seller accused the company of using specialty pharmacies to inflate its revenue.
The company denied the allegation, and later investor Bill Ackman said he increased his Valeant stake by about 2 million shares. The stock pared losses to end down 19.2 percent at $118.61,... More



